✦ LIBER ✦

Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain

✍ Scribed by Rainel Sanchez-de la Rosa, Eliazar Sabater, Miguel A Casado

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND30 Cost Analysis of Glatiramer Acetat

✍ Sánchez-de la Rosa, R.; Sabater, E.; Casado, M.A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PNP15: COST-UTILITY ANALYSIS OF THE TREA

✍ C Rubio-Terrés; F Medina; I Aristegui; G Izquierdo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Efficacy, safety, and cost-effectiveness

✍ Boster, A.; Bartoszek, M. P.; O'Connell, C.; Pitt, D.; Racke, M. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 160 KB

Cost minimisation analysis of fingolimod

✍ Crespo, C.; Izquierdo, G.; García-Ruiz, A.; Granell, M.; Brosa, M. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 480 KB

PND28 Cost-Effectiveness Analysis of Int

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-Effectiveness Analyses of Natalizum

✍ Nishikawa, A.M.; Paladini, L.; Liamas, A.L.; Bueno, C.C.; Clark, O.A.C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB